A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment

Traci R. Rieckmann, Anne E. Kovas, Bentson H. McFarland, Amanda J. Abraham

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

Despite evidence that buprenorphine is effective and safe and offers greater access as compared with methadone, implementation for treatment of opiate dependence continues to be weak. Research indicates that legal and regulatory factors, state policies, and organizational and provider variables affect adoption of buprenorphine. This study uses hierarchical linear modeling to examine National Treatment Center Study data to identify counselor characteristics (attitudes, training, and beliefs) and organizational factors (accreditation, caseload, access to buprenorphine, and other evidence-based practices) that influence implementation of buprenorphine for treatment of opiate dependence. Analyses showed that provider training about buprenorphine, higher prevalence of opiate-dependent clients, and less treatment program emphasis on a 12-step model predicted greater counselor acceptance and perceived effectiveness of buprenorphine. Results also indicate that program use of buprenorphine for any treatment purpose (detoxification, maintenance, and/or pain management) and time (calendar year in data collection) was associated with increased diffusion of knowledge about buprenorphine among counselors and with more favorable counselor attitudes toward buprenorphine.

Original languageEnglish (US)
Pages (from-to)374-385
Number of pages12
JournalJournal of Substance Abuse Treatment
Volume41
Issue number4
DOIs
StatePublished - Dec 2011

Keywords

  • Buprenorphine
  • Multilevel models
  • Opiate dependence
  • Substance abuse counselors

ASJC Scopus subject areas

  • Phychiatric Mental Health
  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment'. Together they form a unique fingerprint.

Cite this